Uyarıcı Maddeler ve Yeni Psikoaktif Maddeler: Epidemiyolojik Eğilimler ve Erken Uyarı Sistemleri
References
Zloh M, Samaras EG, Calvo-Castro J, Guirguis A, Stair JL, Kirton SB. Drowning in diversity? A systematic way of clustering and selecting a representative set of new psychoactive substances. RSC Adv [Internet]. 2017 [cited 2026 Aug 19];7:53181–53191. doi: 10.1039/C7RA09066H.
Global SMART Update. United Nations Office on Drugs and Crime (UNODC). vienna; 2016.
Evans-Brown M, Sedefov R. Responding to New Psychoactive Substances in the European Union: Early Warning, Risk Assessment, and Control Measures. Handb Exp Pharmacol [Internet]. 2018 [cited 2026 Sep 7];252:3–49. doi: 10.1007/164_2018_160. Cited in PMID: 30194542.
Shafi A, Berry AJ, Sumnall H, Wood DM, Tracy DK. New psychoactive substances: a review and updates. Ther Adv Psychopharmacol [Internet]. 2020 [cited 2026 Aug 19];10:2045125320967197. doi: 10.1177/2045125320967197. Cited in PMID: 33414905.
Jaunay EL, Bade R, Paxton KR, Nadarajan D, Barry DC, Zhai Y, Tscharke BJ, O’Brien JW, Mueller J, White JM, et al. Monitoring the use of novel psychoactive substances in Australia by wastewater-based epidemiology. Science of the Total Environment [Internet]. 2024 [cited 2026 Sep 7];919. doi: 10.1016/j.scitotenv.2024.170473. Cited in PMID: 38286292.
Taflaj B, La Maida N, Tittarelli R, Di Trana A, D’Acquarica I. New Psychoactive Substances Toxicity: A Systematic Review of Acute and Chronic Psychiatric Effects. Int J Mol Sci [Internet]. 2024 [cited 2026 Aug 19];25. doi: 10.3390/IJMS25179484. Cited in PMID: 39273431.
Voicu VA, Vasiliu O, Ciobanu A. New psychoactive substances and mental health- Practical challenges for psychiatrists. European Psychiatry. 2025;68:S481–S482. doi: 10.1192/J.EURPSY.2025.1001.
Mounteney J, Griffiths P, Sedefov R, Noor A, Vicente J, Simon R. The drug situation in Europe: An overview of data available on illicit drugs and new psychoactive substances from European monitoring in 2015. Addiction [Internet]. 2016 [cited 2026 Aug 19];111:34–48. doi: 10.1111/ADD.13056;PAGE:STRING:ARTICLE/CHAPTER. Cited in PMID: 26419329.
Narkotik Suçlarla Mücadele Başkanlığı. Türkiye Uyuşturucu Raporu . 2025.
World drug report 2021. United Nations publication,; 2021.
Ricci V, Chiappini S, Martinotti G, Maina G. Novel psychoactive substances and psychosis: A comprehensive systematic review of epidemiology, clinical features, neurobiology, and treatment. Neurosci Biobehav Rev [Internet]. 2025 [cited 2026 Aug 19];178:106384. doi: 10.1016/J.NEUBIOREV.2025.106384. Cited in PMID: 41015167.
Helander A, Bäckberg M, Beck O. Drug trends and harm related to new psychoactive substances (NPS) in Sweden from 2010 to 2016: Experiences from the STRIDA project. PLoS One [Internet]. 2020 [cited 2026 Sep 7];15:e0232038. doi: 10.1371/JOURNAL.PONE.0232038. Cited in PMID: 32324788.
uzbay İT, Kayaalp SO. madde kötüye kullanımı ve madde bağımlılığı. In: Gümüşel B, Babaoğlu MÖ, Melli M, editors. Kayaalp Akılcı Tedavi Yönünden Tıbbi Farmakoloji. 14th ed. Ankara: pelikan yayın evi ; 2024. p. 862–891.
Garus-Pakowska A, Kolmaga A, Gaszyńska E, Ulrichs M. The Scale of Intoxications with New Psychoactive Substances over the Period 2014-2020-Characteristics of the Trends and Impacts of the COVID-19 Pandemic on the Example of Łódź Province, Poland. Int J Environ Res Public Health [Internet]. 2022 [cited 2026 Sep 7];19. doi: 10.3390/IJERPH19084427. Cited in PMID: 35457295.
Devido JJ. Stimulants: Caffeine, Cocaine, Amphetamine, and Other Stimulants. Absolute Addiction Psychiatry Review: An Essential Board Exam Study Guide [Internet]. 2020 [cited 2026 Sep 3];185–203. doi: 10.1007/978-3-030-33404-8_12/SAVE-RESEARCH.
Paz-Ramos MI, Cruz SL, Violante-Soria V. Amphetamine-type Stimulants: Novel Insights into their Actions and use Patterns. Rev Invest Clin [Internet]. 2023 [cited 2026 Aug 19];75:143–157. doi: 10.24875/RIC.23000110. Cited in PMID: 37441770.
Guirguis A, Giorgetti A, Seo J, Corkery JM, Schifano F. Psychopharmacology of Methamphetamine in Relation to the United Kingdom Sentencing Guidance: Comparative Analysis with Amphetamine, Cocaine and Heroin. Brain Sciences 2026, Vol 16, Page 602 [Internet]. 2026 [cited 2026 Aug 19];16:602. doi: 10.3390/BRAINSCI16060602.
Lewis D, Kenneally M, van denHeuvel C, Byard RW. Methamphetamine deaths: Changing trends and diagnostic issues. Med Sci Law [Internet]. 2021 [cited 2026 Aug 19];61:130–137. doi: 10.1177/0025802420986707;PAGEGROUP:STRING:PUBLICATION. Cited in PMID: 33423599.
Guirguis A, Giorgetti A, Seo J, Corkery JM, Schifano F. Psychopharmacology of Methamphetamine in Relation to the United Kingdom Sentencing Guidance: Comparative Analysis with Amphetamine, Cocaine and Heroin. Brain Sciences 2026, Vol 16, Page 602 [Internet]. 2026 [cited 2026 Aug 19];16:602. doi: 10.3390/BRAINSCI16060602.
motycka carol, spillane joseph. kötüye kullanılan ilaçlar. In: Lerchenfeldt S, Giordano C, editors. Farmakoloji. 1st ed. İstanbul: Nobel Tıp Kitapevi; 2023. p. 716–725.
Ligresti A, De Petrocellis L, Di Marzo V. From Phytocannabinoids to Cannabinoid Receptors and Endocannabinoids: Pleiotropic Physiological and Pathological Roles Through Complex Pharmacology. https://doi.org/101152/physrev000022016 [Internet]. 2016 [cited 2026 Sep 7];96:1593–1659. doi: 10.1152/PHYSREV.00002.2016. Cited in PMID: 27630175.
Whiting PF, Wolff RF, Deshpande S, Di Nisio M, Duffy S, Hernandez A V., Keurentjes JC, Lang S, Misso K, Ryder S, et al. Cannabinoids for Medical Use: A Systematic Review and Meta-analysis. JAMA [Internet]. 2015 [cited 2026 Sep 7];313:2456–2473. doi: 10.1001/JAMA.2015.6358. Cited in PMID: 26103030.
What are NPS? [Internet]. [cited 2026 Sep 7]. Available from: https://www.unodc.org/LSS/Page/NPS.
ElSohly MA, Gul W, Wanas AS, Radwan MM. Synthetic cannabinoids: Analysis and metabolites. Life Sci [Internet]. 2014 [cited 2026 Sep 7];97:78–90. doi: 10.1016/J.LFS.2013.12.212. Cited in PMID: 24412391.
Gamage TF, Farquhar CE, Lefever TW, Marusich JA, Kevin RC, McGregor IS, Wiley JL, Thomas BF. Molecular and behavioral pharmacological characterization of abused synthetic cannabinoids MMB- and MDMB-FUBINACA, MN-18, NNEI, CUMYL-PICA, and 5-Fluoro-CUMYL-PICA. Journal of Pharmacology and Experimental Therapeutics [Internet]. 2018 [cited 2026 Sep 7];365:437–446. doi: 10.1124/jpet.117.246983. Cited in PMID: 29549157.
Monteiro JP, Alves MG, Oliveira PF, Silva BM. Structure-Bioactivity Relationships of Methylxanthines: Trying to Make Sense of All the Promises and the Drawbacks. Molecules [Internet]. 2016 [cited 2026 Sep 3];21:974. doi: 10.3390/MOLECULES21080974. Cited in PMID: 27472311.
Buiarelli F, Bernardini F, Simonetti G, Di Filippo P, Pomata D, Riccardi C, Risoluti R. A Rapid and Accurate Method for the Determination of Methylxanthines in Different Nervous System Stimulant Beverages. J AOAC Int [Internet]. 2019 [cited 2026 Sep 3];102:865–871. doi: 10.5740/JAOACINT.18-0351. Cited in PMID: 30704551.
Choi OH, Shamim MT, Padgett WL, Daly JW. Caffeine and theophylline analogues: Correlation of behavioral effects with activity as adenosine receptor antagonists and as phosphodiesterase inhibitors. Life Sci [Internet]. 1988 [cited 2026 Sep 3];43:387–398. doi: 10.1016/0024-3205(88)90517-6. Cited in PMID: 2456442.
Monteiro J, Alves MG, Oliveira PF, Silva BM. Pharmacological potential of methylxanthines: Retrospective analysis and future expectations. Crit Rev Food Sci Nutr [Internet]. 2019 [cited 2026 Sep 3];59:2597–2625. doi: 10.1080/10408398.2018.1461607. Cited in PMID: 29624433.
Soares J, Costa VM, Bastos M de L, Carvalho F, Capela JP. An updated review on synthetic cathinones. Arch Toxicol [Internet]. 2021 [cited 2026 Aug 21];95:2895–2940. doi: 10.1007/S00204-021-03083-3. Cited in PMID: 34100120.
Pieprzyca E, Skowronek R, Czekaj P. Toxicological Analysis of Intoxications with Synthetic Cathinones. J Anal Toxicol [Internet]. 2022 [cited 2026 Aug 21];46:705–711. doi: 10.1093/JAT/BKAB102. Cited in PMID: 34592764.
Kuropka P, Zawadzki M, Szpot P. A review of synthetic cathinones emerging in recent years (2019-2022). Forensic Toxicol [Internet]. 2023 [cited 2026 Aug 21];41:25–46. doi: 10.1007/S11419-022-00639-5. Cited in PMID: 36124107.
Jumbe S, Mwenda Kamninga T, Kalu UG, Nyali J, Saleh L, Newby C, Francis JM. A systematic review and meta-analysis of factors associated with adolescent substance use in Africa, 2000 to 2020. Addiction [Internet]. 2025 [cited 2026 Aug 21];120:1127–1142. doi: 10.1111/ADD.70023;ISSUE:ISSUE:DOI. Cited in PMID: 40016999.
Castaldelli-Maia JM, Bhugra D. Analysis of global prevalence of mental and substance use disorders within countries: focus on sociodemographic characteristics and income levels. Int Rev Psychiatry [Internet]. 2022 [cited 2026 Aug 21];34:6–15. doi: 10.1080/09540261.2022.2040450. Cited in PMID: 35584016.
Degenhardt L, Charlson F, Ferrari A, Santomauro D, Erskine H, Mantilla-Herrara A, Whiteford H, Leung J, Naghavi M, Griswold M, et al. The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Psychiatry [Internet]. 2018 [cited 2026 Aug 21];5:987–1012. doi: 10.1016/S2215-0366(18)30337-7. Cited in PMID: 30392731.
Autellet A, Lacroix C, Batisse A, Micallef J, Fouilhe N, Le Boisselier R, Peyrière H, Eiden C, Network FA, Daveluy A, et al. Monitoring of new psychoactive substances in France: update of addictovigilance data. Eur J Public Health [Internet]. 2026 [cited 2026 Sep 7];36:106. doi: 10.1093/EURPUB/CKAG106. Cited in PMID: 42301951.
Kader A, Hermanns-Clausen M, van Riel A, Faber K, Hondebrink L. Advancing toxicovigilance of recreational drugs, including new psychoactive substances, by using data from four European poison centres. Clin Toxicol (Phila) [Internet]. 2025 [cited 2026 Sep 7];63:23–31. doi: 10.1080/15563650.2024.2430311. Cited in PMID: 39635984.
İlhan MN, Arikan Z, Kotan Z, Tunçoğlu T, Pinarci M, Taşdemir A, Ay B, Koçak N. Prevalence and Socio-Demographic Determinants of Tobacco, Alcohol, Substance Use and Drug Misuse in General Population in Turkey. Noro Psikiyatr Ars [Internet]. 2016 [cited 2026 Aug 21];53:205–212. doi: 10.5152/NPA.2015.10050. Cited in PMID: 28373796.
Ünübol H, Hlzll Sayar G. Prevalence and Sociodemographic Determinants of Substance Use in Turkey. Eur Addict Res [Internet]. 2021 [cited 2026 Aug 21];27:447–456. doi: 10.1159/000515399. Cited in PMID: 33853069.
Sehlikoğlu K, Kamalak M, Dağlıoğlu M, Gülçiçek S, Köse F, Demir HN, Çakır T, Ülkü D, Koca MR, Dönmez D, et al. Evaluation of forensic toxicological characteristics of cases under the age of eighteen with substance use: a sample from Türkiye. Turk J Pediatr [Internet]. 2025 [cited 2026 Aug 21];67:293–303. doi: 10.24953/TURKJPEDIATR.2025.5744. Cited in PMID: 40674764.
Chen H, Liu S, Wang W, Shi H, Gao S, Yan Y, Fang J, Zhan Y, Chen H, Liu Z. Global burden of substance use disorders in adolescents and young adults aged 10–24 years from 1990 to 2021. Scientific Reports 2025 15:1 [Internet]. 2025 [cited 2026 Aug 21];15:25971-. doi: 10.1038/s41598-025-11266-6. Cited in PMID: 40676068.
European Drug Report 2026. 2026.
Assessment of the threat posed by highly potent synthetic opioids in Europe [Internet]. Assessment of the threat posed by highly potent synthetic opioids in Europe . [cited 2026 Aug 19]. Available from: https://www.euda.europa.eu/publications/threat-assessment/assessment-threat-posed-highly-potent-synthetic-opioids-europe_en#download-files.
Founding and early history of the EUDA | The European Union Drugs Agency (EUDA) [Internet]. [cited 2026 Sep 7]. Available from: https://www.euda.europa.eu/about/history_en.
The EU Early Warning System on new psychoactive substances (NPS) | The European Union Drugs Agency (EUDA) [Internet]. The European Union Drugs Agency (EUDA). 2026 [cited 2026 Sep 8]. Available from: https://www.euda.europa.eu/archived/publications/topic-overviews/eu-early-warning-system_en.
Turkish national focal point | The European Union Drugs Agency (EUDA) [Internet]. The European Union Drugs Agency (EUDA). 2026 [cited 2026 Sep 8]. Available from: https://www.euda.europa.eu/about/partners/reitox/t%C3%BCrkiye_en.
Narkotik Suçlarla Mücadele Başkanlığı - Görevlerimiz [Internet]. [cited 2026 Aug 26]. Available from: https://www.narkotik.pol.tr/gorevlerimiz.
Nugteren-van Lonkhuyzen JJ, van den Hengel-Koot IS, Hunault CC, de Lange DW, van Riel AJHP, Hondebrink L. Trends in new psychoactive substance poisonings in the Netherlands: A 14-year retrospective analysis (2012–2025). Addiction [Internet]. 2026 [cited 2026 Sep 7]; doi: 10.1111/ADD.70511;WGROUP:STRING:PUBLICATION.
T.C. İçişleri Bakanlığı - Uyuma Projesi [Internet]. [cited 2026 Aug 26]. Available from: https://www.icisleri.gov.tr/uyuma-projesi.
T.C. İçişleri Bakanlığı Emniyet Genel Müdürlüğü - Narkotim [Internet]. [cited 2026 Aug 26]. Available from: https://www.egm.gov.tr/narkotim.
Uyuşturucu [Internet]. 2026 [cited 2026 Aug 26]. Available from: https://hsgm.saglik.gov.tr/tr/uyusturucu.html.